Background
NCCN guidelines state that chemotherapies for esophageal and gastric carcinomas may be used interchangeably. We interrogated biomarkers from a large cohort of gastroesophageal cancer patients to identify similar and different alterations with therapeutic implications for gastric and esophageal cancers.
Miura JT, Xiu, J, Johnston FM, Turaga KK, Gamblin TC
Download Publication